You can get weight loss medication online without insurance through a licensed telehealth provider if you meet medical eligibility criteria. Options may include FDA-approved brand medications paid cash, pharmacy discount programs, older prescription medications, or compounded GLP-1 medications from state-licensed 503A pharmacies. A clinician must review your health history before prescribing.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you get weight loss medication online without insurance?
Yes. Weight loss medication online can be prescribed without insurance when a licensed clinician decides it is medically appropriate. Online care can handle the visit, prescription decision, follow-up, and sometimes home delivery, but it cannot skip the medical review.
What online providers can and cannot do
A telehealth provider can review your weight history, body mass index (BMI), medical conditions such as type 2 diabetes, prediabetes, hypertension, high cholesterol, obstructive sleep apnea, or PCOS, and current medications. They can prescribe only when the expected benefit is reasonable and the risks are acceptable under clinical standards 3.
Online providers cannot guarantee a prescription, diagnose every condition remotely, or safely prescribe when key information is missing. If symptoms or history suggest another cause of weight change, a clinician may ask for labs, records, or an in-person exam.
Why a prescription is required for GLP-1 medications
Semaglutide and tirzepatide affect appetite, gastric emptying, insulin secretion, and glucagon suppression. They can also cause nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder problems, pancreatitis warnings, and other risks listed in prescribing information 1, 2.
GLP-1 medications may not be appropriate for people with certain medical histories. For example, semaglutide and tirzepatide labels warn against use in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, often called MEN2 1, 2.
When an in-person visit or lab work may still be needed
A clinician may request labs if there are concerns about diabetes, kidney function, liver disease, pregnancy, thyroid disease, or medication interactions. The Endocrine Society guideline recommends that weight-loss medicines be used with lifestyle care and medical monitoring, not as a stand-alone shortcut 3.
What are your main options if you do not have insurance?
The main paths are cash-pay brand prescriptions, discount or savings programs, compounded GLP-1 medications through a licensed provider, older non-GLP-1 prescription medications, and non-prescription products. The right path depends on medical fit, total monthly cost, and safety.
| Option | How it works | Main trade-offs |
|---|---|---|
| Cash-pay brand GLP-1 | A clinician prescribes an FDA-approved medication such as Wegovy, Zepbound, Saxenda, or another labeled option when appropriate. | Often higher retail cost without insurance; availability and pharmacy pricing vary. |
| Manufacturer savings program | Some manufacturers offer savings cards or discount programs. | Many programs have rules, and some require commercial insurance or exclude government insurance. |
| Compounded GLP-1 through a licensed provider | A clinician may prescribe compounded semaglutide or compounded tirzepatide through a state-licensed 503A compounding pharmacy when clinically appropriate. | Compounded medications are not FDA-approved and are not the same as brand medications. |
| Older prescription medications | Options may include orlistat, phentermine/topiramate, naltrexone/bupropion, or metformin in selected cases. | Different benefits, side effects, contraindications, and off-label considerations. |
| Over-the-counter supplements | Products sold without a prescription. | Not the same as prescription obesity treatment; evidence and quality control vary. |
Cash-pay telehealth visit plus retail pharmacy prescription
Some patients pay a telehealth visit fee, then pay the pharmacy cash price for the medication. If the medication is an FDA-approved brand drug, the dose schedule, warnings, and common side effects come from the FDA label 1, 2, 4.
Compounded semaglutide or tirzepatide through a licensed provider
Compounded GLP-1 medications are custom-prepared by a licensed pharmacy for a specific patient prescription. The active ingredients semaglutide and tirzepatide have been studied in large clinical trials, but compounded formulations themselves are not FDA-approved and do not have FDA-evaluated outcomes data 5, 6.
Older non-GLP-1 prescription weight loss medications
Older medications can be useful for some patients, but they are not interchangeable. Orlistat affects fat absorption and can cause oily stools and fat-soluble vitamin issues; phentermine/topiramate has pregnancy-related risks and stimulant-type concerns; naltrexone/bupropion has warnings for blood pressure, seizure risk, and mood-related safety issues 7, 8, 9.
How much can weight loss medication cost without insurance?
Without insurance, the monthly cost can vary widely because the visit fee, medication, labs, shipping, and follow-up may be billed together or separately. Compare total monthly cost, not only the first advertised payment.
Brand GLP-1 prices are often higher for cash-pay patients because the retail price may not include insurance plan discounts or negotiated coverage. Manufacturer pages and pharmacy prices can change, so patients should confirm the current cash price and any savings-card rules before paying.
- Ask whether the medication is included in the listed monthly price.
- Ask whether labs, refills, provider messaging, and shipping are included.
- Ask which medication and form is being prescribed: tablet, injection, nasal spray, or another form.
- Ask where the medication is dispensed and whether the pharmacy is state-licensed.
- Ask how side effects, dose changes, missed doses, and refills are handled.
Which online weight loss medications are commonly discussed?
The medications most often discussed online include semaglutide, tirzepatide, liraglutide, and several non-GLP-1 options. Each has different evidence, risks, and regulatory status.
Semaglutide: Wegovy, Ozempic, Rybelsus, and compounded semaglutide
Semaglutide is a GLP-1 receptor agonist, meaning it acts on the glucagon-like peptide-1 pathway. Wegovy is FDA-approved for chronic weight management in eligible patients; Ozempic and Rybelsus are semaglutide products approved for type 2 diabetes, not as weight-loss brands 1, 10.
In the STEP 1 trial, adults with overweight or obesity who received semaglutide 2.4 mg once weekly plus lifestyle intervention lost more weight than those receiving placebo plus lifestyle intervention over 68 weeks; individual results varied 5. The same section must include safety: gastrointestinal side effects were common, and prescribing information includes warnings about pancreatitis, gallbladder disease, kidney injury, and thyroid C-cell tumor risk 1.
At Chia, compounded semaglutide injection is available through online clinician review when appropriate. Plans currently start at $249/month, and microdosing plans are available when clinically appropriate.
Tirzepatide: Zepbound, Mounjaro, and compounded tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it acts on glucose-dependent insulinotropic polypeptide and GLP-1 pathways. Zepbound is FDA-approved for chronic weight management in eligible patients, and Mounjaro is approved for type 2 diabetes 2, 11.
In the SURMOUNT-1 trial, adults with obesity or overweight and at least one weight-related complication, excluding diabetes, received tirzepatide once weekly at study doses of 5 mg, 10 mg, or 15 mg, and all tirzepatide groups lost more weight than placebo over 72 weeks; individual results varied 6. Side effects and risks include nausea, diarrhea, vomiting, constipation, gallbladder disease, pancreatitis warnings, hypoglycemia risk when used with insulin or insulin secretagogues, and thyroid C-cell tumor warnings 2.
At Chia, compounded tirzepatide tablets and injections are available through online clinician review when appropriate. Tablet plans currently start at $249/month, injection plans currently start at $299/month, and microdosing plans are available when clinically appropriate.
Liraglutide and non-GLP-1 options
Liraglutide is another GLP-1 receptor agonist. Saxenda is approved for chronic weight management, while Victoza is approved for type 2 diabetes; daily injection schedules and side-effect profiles differ from weekly semaglutide or tirzepatide 4, 12.
Non-GLP-1 options include orlistat, phentermine/topiramate, naltrexone/bupropion, and metformin. Metformin is commonly used for type 2 diabetes and is sometimes discussed off-label for weight-related metabolic issues, but off-label use depends on a clinician’s judgment and is not the same as an FDA-approved obesity indication 3.
How do GLP-1 medications help with weight loss?
GLP-1 medications help some people eat less by changing appetite signaling and fullness. They also slow gastric emptying and affect insulin and glucagon, which is why they need medical oversight.
GLP-1 receptor agonists mimic or enhance signals related to satiety, the feeling of being full. Semaglutide prescribing information describes effects on appetite and caloric intake, while tirzepatide acts at both GIP and GLP-1 receptors 1, 2.
These same mechanisms can cause side effects. Slower gastric emptying can contribute to nausea, vomiting, reflux-like symptoms, constipation, or feeling too full; labels also include warnings about pancreatitis, gallbladder disease, severe gastrointestinal reactions, and kidney injury related to dehydration 1, 2.
Lifestyle still matters. Major guidelines describe anti-obesity medication as part of a broader plan that can include nutrition changes, physical activity, sleep, behavior support, and treatment of related conditions 3.
How do brand GLP-1s compare with compounded GLP-1s?
Brand and compounded GLP-1s are not the same category. Brand drugs are FDA-approved products with FDA-reviewed labels, while compounded medications are prepared for an individual prescription by a licensed pharmacy and are not FDA-approved.
| Question | FDA-approved brand GLP-1 | Compounded GLP-1 through a 503A pharmacy |
|---|---|---|
| FDA approval | FDA-approved product with FDA-reviewed labeling. | Not FDA-approved; prepared for an individual prescription. |
| Evidence | Clinical trial data are tied to the specific FDA-approved product and label. | The active ingredient may have clinical trial data, but outcomes are not established for compounded formulations. |
| Prescriber role | Requires clinician evaluation and prescription. | Also requires clinician evaluation and prescription. |
| Pharmacy role | Dispensed by a retail, mail-order, or specialty pharmacy. | Compounded by a state-licensed 503A compounding pharmacy. |
| Safety checks | Use the FDA label, medication guide, and clinician monitoring. | Ask about prescriber review, pharmacy licensing, sterility/potency practices, and follow-up. |
FDA guidance explains that compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug, but compounded drugs do not undergo FDA premarket review for safety, effectiveness, or quality 13. That is why the safety axis is licensed provider plus state-licensed pharmacy, not no-prescription websites.
3-min quiz
Considering online weight loss medication?
Chia offers online clinician review for compounded semaglutide injection and compounded tirzepatide tablets or injections. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
Weight loss medication online at Chia without insurance
At Chia, weight-loss care is 100% online. You complete a short health questionnaire, then a licensed US provider reviews your history and prescribes only when clinically appropriate.
For patients who are eligible, Chia offers compounded semaglutide injection, compounded tirzepatide tablets or injections, and the Weight + Energy protocol, which combines NAD+ injection with a choice of GLP-1 when appropriate. Chia also lists Weight + Muscle, which combines sermorelin injection with a choice of GLP-1 when appropriate; NAD+ and sermorelin components are not FDA-approved weight-loss medications, and benefits for weight-management protocols are not established in FDA-approved obesity labels. Chia medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door.
| Chia option | Forms listed in Chia’s catalog | Current starting price |
|---|---|---|
| Semaglutide | Injection; microdosing plans available when clinically appropriate | From $249/month |
| Tirzepatide | Tablets or injection; microdosing plans available when clinically appropriate | Tablets from $249/month; injection from $299/month |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/month |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | From $329/month |
Dosing is provider-guided and adjusted over time. Patients can message their care team through the patient portal between visits, including questions about side effects, refills, and dose changes.
You can begin with Chia’s eligibility quiz. The quiz starts the online intake; it does not guarantee that a prescription will be written.
Who may be eligible for prescription weight loss medication?
Eligibility usually starts with BMI and weight-related health conditions, but it does not end there. A clinician also reviews safety risks, medications, pregnancy status, and treatment goals.
FDA-approved chronic weight-management medication labels commonly use BMI-based criteria, such as obesity or overweight with at least one weight-related condition. Examples of related conditions include hypertension, high cholesterol, type 2 diabetes, obstructive sleep apnea, and other cardiometabolic risks depending on the medication label 1, 2, 4.
A GLP-1 medication may be inappropriate for some people based on personal or family history, pregnancy plans, pancreatitis history, gallbladder disease, severe gastrointestinal disease, kidney disease, or medication interactions. This is why a real clinician review matters before any prescription 1, 2.
How can you avoid unsafe online weight loss medication sellers?
Unsafe sellers often skip the parts that protect patients: a clinician, a valid prescription, and a real pharmacy. Be careful with any site that offers prescription GLP-1s without medical questions or provider review.
- Red flag: no prescription is required for semaglutide, tirzepatide, or another prescription medication.
- Red flag: the site does not identify a licensed clinician or care team.
- Red flag: the site does not explain which pharmacy dispenses or compounds the medication.
- Red flag: the offer says “Ozempic for $25” but the fine print depends on insurance, a coupon, or a starter-only promotion.
- Red flag: the medication source is described as “research use,” “not for human use,” or shipped without a pharmacy label.
FDA has warned that compounded drugs are not FDA-approved and that patients should not use unapproved versions of GLP-1 drugs from unverified sources 13. A safer online path uses a licensed provider, a clear prescription process, and a state-licensed pharmacy.
What should you ask before choosing an online weight loss program?
Before paying, ask practical questions that reveal the true cost and safety setup. The goal is to know what you are getting, who is responsible for your care, and how follow-up works.
- 1What medication and form is being prescribed?
- 2Is the medication included in the listed price?
- 3Who reviews my health history, and are they licensed in the US?
- 4Where is the medication dispensed or compounded?
- 5Are labs, shipping, refills, and follow-up included or separate?
- 6How are side effects and dose changes handled?
- 7Can I message the care team between visits?
- 8What happens if I am not eligible after the medical review?
3-min quiz
Start with a clinician-reviewed path
If you are exploring online weight-loss care without insurance, Chia’s eligibility quiz can help you start a licensed-provider review. Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injections when clinically appropriate. A prescription is not guaranteed, and compounded drugs are not FDA-approved.
FAQ
The cheapest option depends on the medication, visit fees, pharmacy price, labs, shipping, and follow-up. Some people compare cash-pay brand prescriptions, discount programs, older prescription medications, and compounded GLP-1 care through a licensed provider. Always compare total monthly cost, not only the advertised starter price.
Cash prices can vary by pharmacy, location, dose, coupon rules, and manufacturer programs. Check the current retail price directly with the pharmacy and read any savings-card terms carefully before assuming you qualify.
Be careful with “$25” claims. Many low-price offers depend on insurance coverage, coupon eligibility, or program rules. Ozempic is approved for type 2 diabetes, not as a weight-loss brand, so a clinician must decide whether any use is appropriate.
Yes, a licensed telehealth clinician may prescribe Zepbound online if it is medically appropriate, and you may pay cash without insurance. Cost, supply, and pharmacy access vary, and a prescription is never guaranteed.
Compounded medications may be prescribed for an individual patient and prepared by a licensed compounding pharmacy when legal requirements are met. They are not FDA-approved and are not the same as FDA-approved brand medications.
No. Compounded semaglutide and compounded tirzepatide are not FDA-approved. The active ingredients have been studied in clinical trials, but outcomes are not established for compounded formulations.
Yes. Licensed online clinicians can prescribe weight loss medication when they have enough information and decide the benefits and risks are appropriate. They may also decline to prescribe or ask for labs, records, or an in-person visit.
Some online programs ship medication to your home, while others send a prescription to a retail pharmacy. At Chia, eligible prescriptions are compounded by state-licensed 503A pharmacies and shipped to the patient’s door.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2024.
- 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
- 3.Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2015.
- 4.U.S. Food and Drug Administration. Saxenda (liraglutide) injection prescribing information. 2023.
- 5.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- 6.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- 7.U.S. Food and Drug Administration. Xenical (orlistat) capsules prescribing information. 2015.
- 8.U.S. Food and Drug Administration. Qsymia (phentermine and topiramate extended-release) prescribing information. 2022.
- 9.U.S. Food and Drug Administration. Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets prescribing information. 2021.
- 10.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
- 11.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2025.
- 12.U.S. Food and Drug Administration. Victoza (liraglutide) injection prescribing information. 2023.
- 13.U.S. Food and Drug Administration. Compounded Drugs: Questions and Answers. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
